ZLD 4.11% 70.0¢ zelira therapeutics limited

distant memory as in the climb in sales and beneficial patient...

  1. 4,161 Posts.
    lightbulb Created with Sketch. 8075
    distant memory as in the climb in sales and beneficial patient outcomes will be exponentially irreversible...wink.png
    what that will mean for the sp here is clear...in my opinion
    generated revenue, clinically validated product on the shelves and being prescribed, more in trials nearing completion, expansion into overseas markets complementing the supply and demand which is also exponentially increasing as markets ...both within the US and in countries around the globe transition to a revenue positive model whilst easing the opioid prescription dependency killing patients.....its a no brainer! ...just to highlight but a few points..... IMO
    GLTASAH
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
(20min delay)
Last
70.0¢
Change
-0.030(4.11%)
Mkt cap ! $7.943M
Open High Low Value Volume
73.0¢ 73.0¢ 70.0¢ $1.785K 2.485K

Buyers (Bids)

No. Vol. Price($)
1 2160 70.0¢
 

Sellers (Offers)

Price($) Vol. No.
76.0¢ 733 1
View Market Depth
Last trade - 14.24pm 29/03/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.